Objectives: The number of family physicians in Oman is far below that recommended by the World Health Organization. This study aimed to determine factors influencing junior doctors’ choice of a career in family medicine. Methods: This cross-sectional study was conducted between March and June 2018 and targeted applicants to Oman Medical Specialty Board residency programmes during the 2018–2019 academic year. Applicants were grouped according to their choice of either family medicine (n = 64) or other specialities (n = 81). A self-administered questionnaire was utilised to compare the applicants’ sociodemographic characteristics, factors influencing their choice of career and their Myers-Briggs Type Indicator® (MBTI) personality traits. Results: A total of 52 family medicine and 43 other residency applicants participated in the study (response rates: 81.3% and 53.1%, respectively). Most family medicine applicants were female (86.5%), married (65.4%) and resided in rural areas (73.1%); moreover, 19.2% were ≥30 years of age. Overall, emphasis on continuity of care, opportunity to deal with a variety of medical problems, the ability to use a wide range of skills and knowledge, early exposure to the discipline, opportunity to teach and perform research and the influence of family or friends were important factors in determining choice of a career in family medicine. Moreover, the MBTI analysis revealed that family medicine applicants were commonly extroverted-sensing-thinking-judging personality types. Conclusion: Knowledge of the factors influencing career choice among junior doctors may be useful in determining future admission policies in order to increase the number of family physicians in Oman.Keywords: Career Choice; Internship and Residency; Medical Specialty; Family Practice; Family Physicians; Myers-Briggs Type Indicator; Oman.
BACKGROUND: Previous research has highlighted potential associations between anemia, diabetes, and worsening kidney disease. The aim of this study, therefore, was to determine the prevalence of anemia in patients with both chronic kidney disease (CKD) and Type 2 diabetes mellitus (T2DM) at a primary care center in Oman. MATERIALS AND METHODS: A cross-sectional study was conducted at the Primary Care Clinic of Sultan Qaboos University Hospital, Muscat, Oman. All patients with established diagnoses of CKD and T2DM who attended appointments at the clinic in 2020 and 2021 were included. Data concerning the patients’ sociodemographic characteristics, medical history, clinical findings, and laboratory results during past six months were retrieved from the hospital’s information system. Patients were contacted via telephone for clarification in the event of any missing data. SPSS version 23 was used for Statistical analyses of the data. Frequencies and percentages were used to present categorical variables. Chi-squared tests were used to determine association between anemia and demographic and clinical variables. RESULTS: A total of 300 patients with T2DM and CKD were included in the study; 52% were male, 54.3% were 51–65 years of age, and majority (88%) were either overweight or obese. The majority of patients (62.7%) had Stage 1 CKD followed by Stage 2 (34.3%) and Stage 3 (3%). The total prevalence of anemia was 29.3%, with 31.4%, 24.3%, and 44.4% of Stage 1, Stage 2, and Stage 3 CKD patients being anemic, respectively. The frequency of anemia was significantly higher in female than male patients (41.7% vs. 17.9%; P < 0.001). No associations were observed between anemia status and other sociodemographic or clinical characteristics. CONCLUSION: The prevalence of anemia in CKD and T2DM primary care patients in Oman was 29.3%, with gender as the only factor significantly associated with anemia status. Routine screening of anemia in diabetic nephropathy patients is highly recommended.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.